We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Tim-3 Proteins Shut Down Immune Attack

By Biotechdaily staff writers
Posted on 18 Nov 2003
Researchers have found that the Tim-3 surface protein found on TH1-type helper T cells plays a key role in regulating immune response through modulation of helper cell activity in order to prevent tissue inflammation and development of autoimmune diseases.

Investigators at Harvard Medical School (Boston, MA, USA) used a line of mice with autoimmune diabetes, a condition known to be caused by a TH1 response against insulin-producing cells, to show that the Tim-3 pathway blockade accelerated diabetes in nonobese diabetic mice and prevented acquisition of transplantation tolerance induced by co-stimulation blockade. These findings were published in two papers in the November 2003 issue of Nature Immunology.

"Activated TH1-type helper T cells both participate in and help orchestrate the attack on cells bearing proteins, thereby guarding against infection,” explained senior author Terry Strom, M.D., professor of medicine at Harvard Medical School. "The particular pattern of Tim-3 expression that was found in these two studies suggests that it plays a key role in squelching activation of TH1 T-cells. Nature must have wanted us to have such a mechanism so that once you have created immunity, you have a timely means of ‘turning off' the immune attack.”




Related Links:
Harvard Medical School

New
Gold Member
Automatic Hematology Analyzer
CF9600
New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Multi-Chamber Washer-Disinfector
WD 390
New
All-in-One Molecular System
AIO M160

Latest BioResearch News

Study Identifies Protein Changes Driving Immunotherapy Resistance in Multiple Myeloma
18 Nov 2003  |   BioResearch

Genetic Analysis Identifies BRCA-Linked Risks Across Multiple Cancers
18 Nov 2003  |   BioResearch

Study Identifies Hidden B-Cell Mutations in Autoimmune Disease
18 Nov 2003  |   BioResearch